Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Hold
1,872
0.03% 134
2026
Q1
$227K Sell
1,872
-1,927
-51% -$222K 0.03% 128
2025
Q4
$403K Hold
3,799
0.05% 123
2025
Q3
$322K Buy
3,799
+551
+17% +$45.4K 0.04% 120
2025
Q2
$260K Sell
3,248
-1,907
-37% -$152K 0.03% 133
2025
Q1
$465K Buy
5,155
+1,922
+59% +$179K 0.06% 97
2024
Q4
$324K Sell
3,233
-207
-6% -$21.3K 0.04% 119
2024
Q3
$393K Buy
3,440
+157
+5% +$18.7K 0.05% 103
2024
Q2
$409K Buy
3,283
+996
+44% +$128K 0.06% 96
2024
Q1
$304K Sell
2,287
-2,229
-49% -$275K 0.06% 102
2023
Q4
$496K Buy
4,516
+1,556
+53% +$162K 0.09% 75
2023
Q3
$307K Buy
+2,960
New +$319K 0.02% 90

Other funds holding MRK

Fiducient Advisors's MRK Position: Q2 2026 in Review

Fiducient Advisors held its Merck (MRK) position steady in Q2 2026 at 1,872 shares worth $242K. The position accounts for 0.03% of the portfolio, ranked #134.

Fiducient Advisors first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $496K in Q4 2023. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fiducient Advisors held 1,872 shares of Merck worth $242K as of Q2 2026.
  • Fiducient Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.03% of Fiducient Advisors's portfolio in Q2 2026, its #134 holding.
  • Fiducient Advisors first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Fiducient Advisors's Merck position peaked at $496K in Q4 2023.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fiducient Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.